Magazine Article | June 1, 2021

Don't Overlook The Risks Of Innovative Clinical Trials

Source: Life Science Leader

By Nathalie Smyth, Daniel Brettler, Michele Fields, & Camille Hepsworth

The clinical trials landscape is evolving at an unprecedented pace, being both propelled and incentivized by the global race to advance the COVID-19 vaccines. Advancements in AI and machine learning (ML) for data collection and interpretation and a move toward virtual and adaptive trials and use of real-world data (RWD) have paved the way for the development of novel data collection techniques and analysis. These advancements also could increase the threat of cyberattacks and malicious hacking of private medical data.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader